Medd, P G <br/><br/>
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study.  [electronic resource] 

 -  Bone marrow transplantation  Jul 2013 
 - 982-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2012.261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Age Factors<br/>Alemtuzumab<br/>Allografts<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--etiology<br/>Graft vs Leukemia Effect<br/>Humans<br/>Male<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--mortality<br/>Sex Factors<br/>Societies, Medical<br/>Stem Cell Transplantation<br/>Survival Rate<br/>Transplantation Conditioning<br/>United Kingdom<br/>Vidarabine--administration & dosage